COVID-19 Monoclonal Antibody IV Therapy
Monoclonal Antibody IV therapy
This is a promising form of treatment that can reduce the amount of the SARS-CoV-2 virus in a person’s system. The goal of this therapy is to help:
- prevent hospitalizations
- reduce viral loads
- lessen symptom severity
Who is eligible to receive monoclonal antibody IV therapy?
Monoclonal antibody treatment may be helpful for individuals who:
- Have tested positive for COVID-19
- Have have been exposed to COVID-19
- Are vaccinated OR unvaccinated
- Are in high risk environments
Frequently Asked Questions
Who is not eligible for this treatment?
Individuals would not be eligible for this treatment if they are:
Hospitalized for COVID-19
Requiring oxygen therapy due to COVID-19
Allergic to any of the ingredients in the medication
How long does it take?
The infusion itself takes about 20 minutes. Afterwards there is an hour-long period where patients are monitored. The entire process takes 2 hours.
Are there any side effects?
One possible side effect of monoclonal antibody therapy is an allergic reaction. These reactions typically only occur during infusion or soon after, and your care team will closely monitor for any signs of an allergic reaction. However, because an infusion reaction can also be delayed, contact your doctor immediately if you notice any of the following signs of an allergic reaction:
Fever and/or chills
Shortness of breath
Low blood pressure
Swelling of lips, face or throat
Hives or itchiness
How will I receive monoclonal antibody treatment?
Monoclonal antibody treatment is given to you through a vein (intravenous or IV)
Do I have to test positive for COVID first?
No. Monoclonal antibody treatment can be used as a preventative measure if you believe you have been exposed to COVID-19.
Is this what the President had?
Yes. This is the monoclonal antibody treatment that the President received.
How it Works